PRJ 1217 NHS Breast Cancer Screening Clinical and Administrative services in London

Tender description

NHS England London region are currently preparing for the undertaking of the BCSS re procurement in 2024/25. The aim of the Breast Screening Programme is to reduce mortality from breast cancer by diagnosing cancer at an early stage when treatment is more successful, leading to earlier detection, appropriate referral, and improved outcomes. Commissioners are seeking feedback from interested organisations via a Market Engagement Questionnaires (MEQ). The MEQ will also allow potential bidders to express an interest in becoming a member of the Clinical Reference Group and Admin Hub Reference Group. To access the MEQ, interested organisation must express an interest. Please note that any expressions of interest by any other means will not be considered. Once you have expressed an interest, navigate to the project area where you can access the Market Engagement materials provided in the messaging facility (including a link to the MEQ via MS Forms). Interested organisations are requested to complete and submit a copy of the Market Engagement Questionnaire through the MS Form no later than Wednesday 13th September 2023 at 12.00 (noon). Please note that this expression of interest is for the Market Engagement Questionnaire only. You will need to Express an Interest again once the procurement is live, which is likely to be on the Atamis Health Family (HF) eCommercial System. The service specifications, lot structures and indicative dates stipulated are all in draft and are being developed at the time of publication of this PIN. Feedback from this MEQ exercise will be considered by the commissioners before the service specification and other contract parameters are finalised for the next stage of the process. Keywords: Breast Screening , Breast Cancer Screening